Vital Basics settlement
This article was originally published in The Tan Sheet
Executive SummaryFocus Factor and V-Factor supplement marketer Vital Basics will pay $1 mil. in consumer redress in a settlement over false and unsubstantiated ad claims for the products, FTC announces March 17. Under the agreement, the company is prohibited from making performance claims for any food, drug or supplement for brain and mental functions, sexual response and enhancement or the treatment, cure or prevention of any disorder. Creative Health Institute also settles with FTC, agrees to pay $60,000 in consumer redress and cease making claims about Focus Factor's enhancement of mood, focus, memory and concentration...
You may also be interested in...
Johnson & Johnson has achieved exceptional growth in recent years, and a raft of new products is set to sustain it further.
Bayer’s drive to lead a new market opportunity in Europe for histology-independent cancer agents like Vitrakvi has been set back by interim decisions from the UK’s NICE and Germany’s IQWiG, but there is a now a clear pathway to follow.
Performance-based managed entry agreements need to be made more effective, but this can only happen if countries relax their stance on confidentiality and share information on MEAs amongst themselves, says a working paper from the OECD.